Sec. 2. DEFINITIONS
426 words·~2 min read·
/statute-compilations/comps-17095/sec-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 2 DEFINITIONS ###
(a)In General **[**[21 U.S.C. 801 note](/us/usc/t21/s801)**]** In this Act— ####
(1)the term “**appropriately registered**” means that an individual or entity is registered under the Controlled Substances Act (21 U.S.C. 801 et seq.) to engage in the type of activity that is carried out by the individual or entity with respect to a controlled substance on the schedule that is applicable to cannabidiol or marijuana, as applicable; ####
(2)the term “**cannabidiol**” means— #####
(A)the substance, cannabidiol, as derived from marijuana that has a delta-9-tetrahydrocannabinol level that is greater than 0.3 percent; and #####
(B)the synthetic equivalent of the substance described in subparagraph (A); ####
(3)the terms “controlled substance”, “dispense”, “distribute”, “manufacture”, “marijuana”, and “practitioner” have the meanings given such terms in section 102 of the Controlled Substances Act (21 U.S.C. 802), as amended by this Act; ####
(4)the term “**covered institution of higher education**” means an institution of higher education (as defined in section 101 of the Higher Education Act of 1965 (20 U.S.C. 1001)) that— #####
(A)######
(i)has highest or higher research activity, as defined by the Carnegie Classification of Institutions of Higher Education; or ######
(ii)is an accredited medical school or an accredited school of osteopathic medicine; and #####
(B)is appropriately registered under the Controlled Substances Act (21 U.S.C. 801 et seq.); ####
(5)the term “**drug**” has the meaning given the term in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1)); ####
(6)the term “**medical research for drug development**” means medical research that is— #####
(A)a preclinical study or clinical investigation conducted in accordance with section 505(i) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(i)) or otherwise permitted by the Department of Health and Human Services to determine the potential medical benefits of marijuana or cannabidiol as a drug; and #####
(B)conducted by a covered institution of higher education, practitioner, or manufacturer that is appropriately registered under the Controlled Substances Act (21 U.S.C. 801 et seq.); and ####
(7)the term “**State**” means any State of the United States, the District of Columbia, and any territory of the United States. ###
(b)Updating Term Section 102(16) of the Controlled Substances Act (21 U.S.C. 802(16)) is amended— ####
(1)in subparagraph (A), by striking “**the term ‘marihuana’ means**” and inserting “**the terms ‘marihuana’ and ‘marijuana’ mean**”; and ####
(2)in subparagraph (B), by striking “**The term ‘marihuana’ does not**” and inserting “**The terms ‘marihuana’ and ‘marijuana’ do not**”.
Connectionstraces to 5
Citation graph
cites case law
Cites 5Cited by 0 across 0 sources